CH427803A - Verfahren zur Herstellung eines neuen Isoxazolderivates - Google Patents

Verfahren zur Herstellung eines neuen Isoxazolderivates

Info

Publication number
CH427803A
CH427803A CH1495463A CH1495463A CH427803A CH 427803 A CH427803 A CH 427803A CH 1495463 A CH1495463 A CH 1495463A CH 1495463 A CH1495463 A CH 1495463A CH 427803 A CH427803 A CH 427803A
Authority
CH
Switzerland
Prior art keywords
production
isoxazole derivative
new isoxazole
new
derivative
Prior art date
Application number
CH1495463A
Other languages
English (en)
Inventor
Andre Dr Gagneux
Frank Dr Haefliger
Eugster Conrad Dr Prof
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Priority to CH1495463A priority Critical patent/CH427803A/de
Priority to US41579564 priority patent/US3242190A/en
Priority to GB4931864A priority patent/GB1034939A/en
Priority to DE19641445848 priority patent/DE1445848A1/de
Priority to IL22568A priority patent/IL22568A/en
Priority to AT1030064A priority patent/AT249054B/de
Priority to SE1469364A priority patent/SE301652B/xx
Priority to NL6414138A priority patent/NL6414138A/xx
Priority to AT476065A priority patent/AT250348B/de
Priority to DK444165A priority patent/DK106733C/da
Priority to DK599664A priority patent/DK106796C/da
Priority to FR997579A priority patent/FR1427775A/fr
Priority to ES0306818A priority patent/ES306818A1/es
Priority to ES0306819A priority patent/ES306819A1/es
Priority to DK443965A priority patent/DK108169C/da
Priority to ES0306820A priority patent/ES306820A1/es
Priority to ES0306817A priority patent/ES306817A1/es
Priority to DK444065A priority patent/DK106797C/da
Priority to ES0306816A priority patent/ES306816A1/es
Priority to BE656759D priority patent/BE656759A/xx
Priority to FR7870A priority patent/FR4139M/fr
Priority to SE27667A priority patent/SE303507B/xx
Priority to SE27767A priority patent/SE304513B/xx
Publication of CH427803A publication Critical patent/CH427803A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
CH1495463A 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates CH427803A (de)

Priority Applications (23)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates
US41579564 US3242190A (en) 1963-12-06 1964-12-03 3-hydroxy-5-aminomethylisoxazole compounds
GB4931864A GB1034939A (en) 1963-12-06 1964-12-04 Isoxazole derivative and processes for its production
DE19641445848 DE1445848A1 (de) 1963-12-06 1964-12-04 Verfahren zur Herstellung eines neuen Isoxazolderivates
IL22568A IL22568A (en) 1963-12-06 1964-12-04 3-hydroxy-5-aminomethyl-isoxazole
AT1030064A AT249054B (de) 1963-12-06 1964-12-04 Verfahren zur Herstellung des neuen 3-Hydroxy-5-aminomethyl-isoxazols
SE1469364A SE301652B (de) 1963-12-06 1964-12-04
NL6414138A NL6414138A (de) 1963-12-06 1964-12-04
AT476065A AT250348B (de) 1963-12-06 1964-12-04 Verfahren zur Herstellung des neuen 3-Hydroxy-5-aminomethyl-isoxazols
DK444165A DK106733C (da) 1963-12-06 1964-12-05 Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxazol eller syreadditionssalte deraf.
DK599664A DK106796C (da) 1963-12-06 1964-12-05 Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxazol eller syreadditionssalte deraf.
FR997579A FR1427775A (fr) 1963-12-06 1964-12-05 Nouveau dérivé de l'oxazole-1.2 et sa préparation
ES0306818A ES306818A1 (es) 1963-12-06 1964-12-05 Procedimiento para preparar un nuevo derivado de isoxazol.
ES0306819A ES306819A1 (es) 1963-12-06 1964-12-05 Procedimiento para la preparacion de un nuevo derivado de isoxazol.
DK443965A DK108169C (da) 1963-12-06 1964-12-05 Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxasol eller syreadditionssalte deraf.
ES0306820A ES306820A1 (es) 1963-12-06 1964-12-05 Procedimiento para preparar un nuevo derivado de isoxazol.
ES0306817A ES306817A1 (es) 1963-12-06 1964-12-05 Procedimiento para preparar un nuevo derivado de isoxazol.
DK444065A DK106797C (da) 1963-12-06 1964-12-05 Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxazol eller syreadditionssalte deraf.
ES0306816A ES306816A1 (es) 1963-12-06 1964-12-05 Procedimiento para preparar un nuevo derivado de isoxazol.
BE656759D BE656759A (de) 1963-12-06 1964-12-07
FR7870A FR4139M (de) 1963-12-06 1965-03-04
SE27667A SE303507B (de) 1963-12-06 1967-01-09
SE27767A SE304513B (de) 1963-12-06 1967-01-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
CH427803A true CH427803A (de) 1967-01-15

Family

ID=4405150

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Country Status (12)

Country Link
US (1) US3242190A (de)
AT (2) AT250348B (de)
BE (1) BE656759A (de)
CH (1) CH427803A (de)
DE (1) DE1445848A1 (de)
DK (4) DK108169C (de)
ES (5) ES306817A1 (de)
FR (2) FR1427775A (de)
GB (1) GB1034939A (de)
IL (1) IL22568A (de)
NL (1) NL6414138A (de)
SE (3) SE301652B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (de) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
ES2230378T3 (es) 2000-11-30 2005-05-01 Pfizer Products Inc. Combinacion de agonistas de gaba e inhibidores de sorbitol deshidrogenasa.
KR20030059287A (ko) 2000-11-30 2003-07-07 화이자 프로덕츠 인코포레이티드 Ｇａｂａ 작용제 및 알도스 리덕타제 억제제의 혼합물
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
DK1691811T3 (da) 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
CA2553291A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combination of .gamma.-aminobutyric acid modulators and 5-ht1b receptor antagonists
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1991212A1 (de) * 2006-03-08 2008-11-19 Braincells, Inc. Neurogenesemodulation durch nootropika
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2382975A3 (de) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Also Published As

Publication number Publication date
AT250348B (de) 1966-11-10
NL6414138A (de) 1965-06-07
FR1427775A (fr) 1966-02-11
SE304513B (de) 1968-09-30
DK106733C (da) 1967-03-13
ES306820A1 (es) 1965-05-16
BE656759A (de) 1965-06-08
SE301652B (de) 1968-06-17
ES306819A1 (es) 1965-05-16
DE1445848A1 (de) 1968-11-21
AT249054B (de) 1966-09-26
SE303507B (de) 1968-09-02
GB1034939A (en) 1966-07-06
ES306816A1 (es) 1965-05-16
ES306817A1 (es) 1965-05-16
ES306818A1 (es) 1965-05-16
IL22568A (en) 1968-04-25
DK106796C (da) 1967-03-20
FR4139M (de) 1966-05-02
DK106797C (da) 1967-03-20
US3242190A (en) 1966-03-22
DK108169C (da) 1967-10-02

Similar Documents

Publication Publication Date Title
CH427803A (de) Verfahren zur Herstellung eines neuen Isoxazolderivates
AT255769B (de) Verfahren zur Herstellung eines neuen Kunststoffes
AT269356B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT285065B (de) Verfahren zur Herstellung eines neuen Pentacosapeptids
AT270067B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT251775B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT251208B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT290011B (de) Verfahren zur Herstellung eines neuen Antibiotikums
CH453176A (de) Verfahren zur Herstellung eines Leuchtsatzes
AT252474B (de) Verfahren zur Herstellung eines neuen Polypeptids
CH469089A (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT267063B (de) Verfahren zur Herstellung eines neuen Antibioticums
AT262994B (de) Verfahren zur Herstellung eines neuen Phenylbutazonderivates
AT251207B (de) Verfahren zur Herstellung eines neuen Polypeptids
CH464204A (de) Verfahren zur Herstellung neuer Isoxazole
AT254208B (de) Verfahren zur Herstellung eines neuen Harnstoffderivates
CH467027A (de) Verfahren zur Herstellung eines getrockneten Mikroorganismenpräparats
AT290013B (de) Verfahren zur Herstellung eines neuen Antibiotikums
CH444158A (de) Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
CH459190A (de) Verfahren zur Herstellung eines neuen Cardenolids
CH460011A (de) Verfahren zur Herstellung eines neuen Conenin-Derivates
CH442302A (de) Verfahren zur Herstellung eines neuen Indolderivates
CH476102A (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT255028B (de) Verfahren zur Herstellung eines neuen Antibiotikums
CH461707A (de) Verfahren zur Herstellung eines neuen Antibiotikums